Pasar al contenido principal

BIOSONDAS BASADAS EN LANTANIDOS PARA LA OBTENCION DE BIOIMAGEN MEDIANTE RESONANCIA MAGNETICA Y LUMINISCENCIA PERSISTENTE

PID2021-122328OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mn2+-doped MgGeO3 nanophosphors with controlled shape and optimized persistent luminescence

  • González-Mancebo, Daniel
  • Arroyo, Encarnación
  • Becerro, Ana Isabel
  • Ocaña, Manuel
Mn2+-doped MgGeO3 (MgGeO3:Mn2+) is an efficient persistent phosphor that emits red luminescence for long time after stopping excitation with UV light. For optical and biotechnological uses a precise control of particle size and shape is highly desired since these parameters may have a strong influence on the properties and suitability of phosphor materials for the intended applications. To the best of our knowledge, MgGeO3:Mn2+ has been synthesized by conventional solid-state-reaction, which yields particles of heterogeneous size and shape. Here, we report for the first time in the literature a salt-assisted method for the synthesis of MgGeO3:Mn2+ nanoparticles with uniform shape (nanorods) and a mean size of 350 nm × 99 nm. The rigorous study of the luminescence properties of the MgGeO3:Mn2+ nanorods revealed that whereas the optimum doping level for photoluminescence was 2.0 mol% Mn2+, the best persistent luminescence was attained with just 0.5 mol% Mn2+, which is ascribed to the different mechanisms of both luminescence processes. The optimum persistent nanophosphor showed an intense red emission, which persisted at least 17 h after stopping the excitation. Such excellent properties make the developed nanophosphor an attractive candidate for use in optical and biotechnological applications., This publication is part of the I + D + I Grant PID2021-122328OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. E.A. acknowledges Grant FPU19/00527 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lanthanide vanadate-based trimodal probes for near-infrared luminescent bioimaging, high-field magnetic resonance imaging, and X-ray computed tomography

  • Gómez-González, Elisabet
  • González-Mancebo, Daniel
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Becerro, Ana Isabel
  • Ocaña, Manuel
We have developed a trimodal bioimaging probe for near-infrared luminescent imaging, high-field magnetic resonance imaging, and X-ray computed tomography using Dy3+ as the paramagnetic component and Nd3+ as the luminescent cation, both of them incorporated in a vanadate matrix. Among different essayed architectures (single phase and core–shell nanoparticles) the one showing the best luminescent properties is that consisting of uniform DyVO4 nanoparticles coated with a first uniform layer of LaVO4 and a second layer of Nd3+-doped LaVO4. The magnetic relaxivity (r2) at high field (9.4 T) of these nanoparticles was among the highest values ever reported for this kind of probes and their X-ray attenuation properties, due to the presence of lanthanide cations, were also better than those of a commercial contrast agent (iohexol) commonly used for X-ray computed tomography. In addition, they were chemically stable in a physiological medium in which they could be easily dispersed owing to their one-pot functionalization with polyacrylic acid, and, finally, they were non-toxic for human fibroblast cells. Such a probe is, therefore, an excellent multimodal contrast agent for near-infrared luminescent imaging, high-field magnetic resonance imaging, and X-ray computed tomography., Financial support by Junta de Andalucía (P20_00182) is acknowledged. This publication is part of the I + D + I Grants RTI2018-094426-B-I00, PID2021-122328OB-I00, and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged. High-field relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Persistent Luminescence Zn2GeO4:Mn2+ Nanoparticles Functionalized with Polyacrylic Acid: One-Pot Synthesis and Biosensing Applications

  • Calderón-Olvera, Roxana M.
  • Arroyo, Encarnación
  • Jankelow, Aaron M.
  • Bashir, Rashid
  • Valera, Enrique
  • Ocaña, Manuel
  • Becerro, Ana Isabel
Zinc germanate doped with Mn2+ (Zn2GeO4:Mn2+) is known to be a persistent luminescence green phosphor with potential applications in biosensing and bioimaging. Such applications demand nanoparticulated phosphors with a uniform shape and size, good dispersibility in aqueous media, high chemical stability, and surface-functionalization. These characteristics could be major bottlenecks and hence limit their practical applications. This work describes a one-pot, microwave-assisted hydrothermal method to synthesize highly uniform Zn2GeO4:Mn2+ nanoparticles (NPs) using polyacrylic acid (PAA) as an additive. A thorough characterization of the NPs showed that the PAA molecules were essential to realizing uniform NPs as they were responsible for the ordered aggregation of their building blocks. In addition, PAA remained attached to the NPs surface, which conferred high colloidal stability to the NPs through electrostatic and steric interactions, and provided carboxylate groups that can act as anchor sites for the eventual conjugation of biomolecules to the surface. In addition, it was demonstrated that the as-synthesized NPs were chemically stable for, at least, 1 week in phosphate buffer saline (pH range = 6.0-7.4). The luminescence properties of Zn2GeO4 NPs doped with different contents of Mn2+ (0.25-3.00 mol %) were evaluated to find the optimum doping level for the highest photoluminescence (2.50% Mn) and the longest persistent luminescence (0.50% Mn). The NPs with the best persistent luminescence properties were photostable for at least 1 week. Finally, taking advantage of such properties and the presence of surface carboxylate groups, the Zn2GeO4:0.50%Mn2+ sample was successfully used to develop a persistent luminescence-based sandwich immunoassay for the autofluorescence-free detection of interleukin-6 in undiluted human serum and undiluted human plasma samples. This study demonstrates that our persistent Mn-doped Zn2GeO4 nanophosphors are ideal candidates for biosensing applications., This publication is part of the I + D + I Grant PID2021- 122328OB-I00 funded by MCIN/AEI/10.13039/ 501100011033 and by “ERDF A way of making Europe.” R.M.C.-O. acknowledges financial support from the CONACYT- 801024. Grant FPU19/00527 was funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. E.A. thanks Ministerio de Universidades for a short stay grant (EST21/00458) at the Department of Bioengineering, University of Illinois at Urbana-Champaign. R.B. and E.V. acknowledge support from the National Institutes of Health (R01AI148385)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Highly Nonstoichiometric YAG Ceramics with Modified Luminescence Properties

  • Cao, Weiwei
  • Becerro, Ana Isabel
  • Castaing, Victor
  • Fang, Xue
  • Florian, Pierre
  • Fayon, Franck
  • Zanghi, Didier
  • Veron, Emmanuel
  • Zandonà, Alessio
  • Genevois, Cécile
  • Pitcher, Michael
  • Allix, Mathieu
Y3Al5O12 (YAG) is a widely used phosphor host. Its optical properties are controlled by chemical substitution at its YO8 or AlO6/AlO4 sublattices, with emission wavelengths defined by rare-earth and transition-metal dopants that have been explored extensively. Nonstoichiometric compositions Y3+xAl5-xO12 (x ≠ 0) may offer a route to new emission wavelengths by distributing dopants over two or more sublattices simultaneously, producing new local coordination environments for the activator ions. However, YAG typically behaves as a line phase, and such compositions are therefore challenging to synthesize. Here, a series of highly nonstoichiometric Y3+xAl5-xO12 with 0 ≤ x ≤ 0.40 is reported, corresponding to ≤20% of the AlO6 sublattice substituted by Y3+, synthesized by advanced melt-quenching techniques. This impacts the up-conversion luminescence of Yb3+/Er3+-doped systems, whose yellow-green emission differs from the red-orange emission of their stoichiometric counterparts. In contrast, the YAG:Ce3+ system has a different structural response to nonstoichiometry and its down-conversion emission is only weakly affected. Analogous highly nonstoichiometric systems should be obtainable for a range of garnet materials, demonstrated here by the synthesis of Gd3.2Al4.8O12 and Gd3.2Ga4.8O12. This opens pathways to property tuning by control of host stoichiometry, and the prospect of improved performance or new applications for garnet-type materials., Financial support was provided by the ANR-18-CE08-0012 PERSIST and ANR-20-CE08-0007 CAPRE projects of the French National Research Agency (ANR) and the CNRS, the I+D+I Grants PID2021-122328OB-100 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. PhD studentships for WC and XF were financed by the Chinese Scholarship Council (project numbers 201808450100 and 202008450026). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U. S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. EXAFS beamtime was provided by the SOLEIL synchrotron (Gif-sur-Yvette, France) under project 99210047. The project benefitted from the microscopy facilities of the Platform MACLE-CVL which was co-funded by the European Union and Centre-Val de Loire Region (FEDER)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset - Nanoparticulated Bimodal Contrast Agent for Ultra-High-Field Magnetic Resonance Imaging and Spectral X-ray Computed Tomography

  • González-Mancebo, Daniel
  • Becerro, Ana Isabel
  • Caro, Carlos
  • Gómez-González, Elisabet
  • García-Martín, María L.
  • Ocaña, Manuel
File List: Fig 1 F1b: Size histogram of Ba40Dy60 NPs F1c: EDX spectrum of Ba40Dy60 NPs F1e: Size histogram of Ba51Dy49 NPs F1f: F1c: EDX spectrum of Ba51Dy49 NPs Fig 2 F2: Experimental XRD patterns of Ba40Dy60 and Ba51Dy49 samples Fig 3 F3b: XRD patterns of the precipitates obtained in the conditions used for the synthesis of Ba51Dy49 NPs but using different aging times F3c: Unit cell parameters and Ba/(Ba+Dy) ratio of the precipitates versus aging time Fig 4 F4a: DLS intensity curves of the Ba51Dy49 NPs suspended in water after different periods of time at rest F4b: FTIR spectrum of the Ba51Dy49 NPs Fig 5 F5g: Total number of cells per well after exposure to increasing concentration of NPs F5h: Percentage of dead cells after exposure to increasing concentration of Ba51Dy49 NPs. F5i: MTT assay of cells exposed to increasing concentration of Ba51Dy49 NPs Fig 6 F6a: 1/T2 values obtained in aqueous suspensions of Ba51Dy49 NPs at 9.4 T and 1.44 T versus Dy concentration of the suspensions Fig 7 F7b: X-ray attenuation at 80 kVp, in Hounsfield Units (HU), of aqueous suspensions containing Ba51Dy49 NPs and Iohexol, versus suspension concentration. F7c: X-ray attenuation, in HU, of aqueous suspensions containing 20.0 mg·mL-1 of Ba51Dy49 and DyF3 NPs, versus working voltage, Bimodal medical imaging based on Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) is a well-known strategy to increase diagnostic accuracy. The most recent advances in MRI and CT instrumentation are related to the use of ultrahigh magnetic fields (UHF-MRI) and different working voltages (spectral CT), respectively. Such advances require the parallel development of bimodal contrast agents (CAs) that are efficient under the new instrumental conditions. In this work, we have synthesized, through a precipitation reaction from a glycerol solution of the precursors, uniform barium dysprosium fluoride nanospheres with cubic fluorite structure, whose size was found to depend on the Ba/(Ba+Dy) ratio of the starting solution. Moreover, irrespective of the starting Ba/(Ba+Dy) ratio, the experimental Ba/(Ba+Dy) values were always lower than those used in the starting solutions. This result was assigned to a lower precipitation kinetics of barium fluoride compared to dysprosium fluoride, as inferred from the detailed analysis of the effect of reaction time on the chemical composition of the precipitates. A sample composed of 34 nm nanospheres with a Ba0.51Dy0.49F2.49 stoichiometry, showed a transversal relaxivity (r2) value of 147.11 mM-1·s-1 at 9.4 T and gave a high negative contrast in the phantom image. Likewise, it produced high X-ray attenuation in a large range of working voltages (from 80 KVp to 140 KVp), which can be attributed to the presence of different K-edge values, high Z elements (Ba and Dy) in the nanospheres. Finally, these nanospheres showed negligible cytotoxicity for different biocompatibility tests. Taken together, these results show that the reported nanoparticles (NPs) are excellent candidates as UHF MRI/Spectral CT bimodal imaging CAs., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. High-field relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Nanoparticulated Bimodal Contrast Agent for Ultra-High-Field Magnetic Resonance Imaging and Spectral X-ray Computed Tomography

  • González-Mancebo, Daniel
  • Becerro, Ana Isabel
  • Caro, Carlos
  • Gómez-González, Elisabet
  • García-Martín, María Luisa.
  • Ocaña, Manuel
Chemicals and CAS Registry Numbers barium 7440-39-3 dysprosium 7429-91-6 fluoride 16984-48-8, Bimodal medical imaging based on magnetic resonance imaging (MRI) and computed tomography (CT) is a well-known strategy to increase the diagnostic accuracy. The most recent advances in MRI and CT instrumentation are related to the use of ultra-high magnetic fields (UHF-MRI) and different working voltages (spectral CT), respectively. Such advances require the parallel development of bimodal contrast agents (CAs) that are efficient under new instrumental conditions. In this work, we have synthesized, through a precipitation reaction from a glycerol solution of the precursors, uniform barium dysprosium fluoride nanospheres with a cubic fluorite structure, whose size was found to depend on the Ba/(Ba + Dy) ratio of the starting solution. Moreover, irrespective of the starting Ba/(Ba + Dy) ratio, the experimental Ba/(Ba + Dy) values were always lower than those used in the starting solutions. This result was assigned to lower precipitation kinetics of barium fluoride compared to dysprosium fluoride, as inferred from the detailed analysis of the effect of reaction time on the chemical composition of the precipitates. A sample composed of 34 nm nanospheres with a Ba0.51Dy0.49F2.49 stoichiometry showed a transversal relaxivity (r2) value of 147.11 mM-1·s-1 at 9.4 T and gave a high negative contrast in the phantom image. Likewise, it produced high X-ray attenuation in a large range of working voltages (from 80 to 140 kVp), which can be attributed to the presence of different K-edge values and high Z elements (Ba and Dy) in the nanospheres. Finally, these nanospheres showed negligible cytotoxicity for different biocompatibility tests. Taken together, these results show that the reported nanoparticles are excellent candidates for UHF-MRI/spectral CT bimodal imaging CAs., This publication is part of the I + D + I grants PID2021-122328OB-I00 and PID2020-118448RB-C21 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, cofinanced by EU FEDER funds. High-field relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset - Multimodal lanthanide vanadate-based nanoparticles for T1 -T2 MRI and NIR luminescent imaging

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Becerro, Ana Isabel
  • Ocaña, Manuel
We report the development of a multimodal lanthanide vanadate system suitable as dual T1-T2 MRI contrast agent as well as a luminescent imaging probe in the near-infrared region, using Dy3+ and Gd3+ as T2 and T1 components, respectively, and Nd3+ as the luminescent center. The vanadate matrix was chosen to avoid the undesired solubility associated to previously reported fluoride-based contrast agents. With such aim, we first optimized the design of the MRI system by comparatively evaluating the magnetic relaxivities of two different architectures consisting of i) uniform NPs incorporating both paramagnetic cations in solid solution (single-phase NPs), and ii) core-shell NPs consisting of a DyVO4 core coated with a homogeneous GdVO4 shell (DyVO4@GdVO4). We found that, although both samples presented magnetic relaxivity properties that make them adequate for their use as dual T1-T2 contrast agents for magnetic resonance imaging, the core-shell architecture would be more suitable because of their higher magnetic relaxivity values. Secondly, to prepare the multimodal system, the GdVO4 layer of such optimal dual T1-T2 MRI probe was doped with Nd3+ cations. An inert YVO4 intermediate shell was also introduced between the cores and the outer layer aiming to avoid energy transfer from Nd3+ to Dy3+, which would cause luminescence quenching. These core-shell-shell nanoparticles showed magnetic relaxivity values similar to those of the core-shell system and an intense luminescence in the near-infrared region. Moreover, they were dispersible and chemically stable under conditions that mimic the physiological media, and they were nontoxic for cells. Therefore, such multimodal nanoparticles meet the main requirements for their use as a dual T1-T2 contrast agent for magnetic resonance imaging and as a probe for luminescent imaging in the near-infrared region., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged., F2 F2b_ FTIR spectrum of single-phase nanoparticles. F2c_ TGA curve of the single-phase nanoparticles. F2d_XRD pattern of the single-phase nanoparticles_ black. F2d_GdVO4 PDF_red. F2d_DyVO4 PDF_navy. F4 F4b_ XRD pattern of the core-shell nanoparticles_ black F4b_GdVO4 PDF_red. F4b_DyVO4 PDF_navy. F4c: FTIR spectrum of the core-shell nanoparticles. F4d: TGA curve of the core-shell nanoparticles. F6 F6_top_blue: The longitudinal (1/T1) relaxation rates at 1.44 T for different contents of single-phase nanoparticles. F6_top_red: The longitudinal (1/T1) relaxation rates at 1.44 T for different contents of core-shell nanoparticles. F6_bottom_blue: The transverse (1/T2) relaxation rates at 1.44 T for different contents of single-phase nanoparticles. F6_bottom_red: The transverse (1/T2) relaxation rates at 1.44 T for different contents of core-shell nanoparticles. F7 F7b_XRD pattern of the Dy@Y@Nd:Gd sample_black. F7b_DyVO4 PDF_grey. F7b_GdVO4 PDF_red F7b_YVO4 PDF_blue F7c_FTIR spectrum of the Dy@Y@Nd:Gd sample. F7d_TGA curve of the Dy@Y@Nd:Gd sample. F9 F9_blue: Relaxation rates (1/T1) measured at 1.44 T for different lanthanide (Dy+Gd+Nd) concentration in the Dy@Y@Nd:Gd sample. F9_red: Relaxation rates (1/T2) measured at 1.44 T for different lanthanide (Dy+Gd+Nd) concentration in the Dy@Y@Nd:Gd sample. F10 F10_top: Excitation spectrum for the Dy@Y@Nd:Gd sample. F10_ bottom: Emission spectrum for the Dy@Y@Nd:Gd sample. F11 F11_grey: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in water. F11_red: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in MES medium. F11_blue: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in PBS medium. F11_green: DLS curve obtained for DyVO4@YVO4@Nd-doped GdVO4 nanoparticles suspensions in saline medium. F12 F12_Histogram_1 day: Histogram of Dy@Y@Nd:Gd nanoparticles after aging in PBS medium at 37 ºC during one day. F12_Histogram_21 days: Histogram of Dy@Y@Nd:Gd nanoparticles after aging in PBS medium at 37 ºC during 21 days. F12_Histogram_35 days: Histogram of Dy@Y@Nd:Gd nanoparticles after aging in PBS medium at 37 ºC during 35 days. F13 F13d_Analysis of the total number of cells per well exposed to increasing concentration of DyVO4@YVO4@Nd-doped GdVO4 nanoparticles. F13e_Dead cell percentage to increasing concentration of DyVO4@YVO4@Nd-doped GdVO4 nanoparticles. F13f_Mitochondrial activity of the cells to increasing concentration of DyVO4@YVO4@Nd-doped GdVO4 nanoparticles. FS1 FS1a_Size distribution histogram of the single-phase nanoparticles containing Gd and Dy as a solid solution. FS1b_Size distribution histogram of the DyVO4 nanoparticles coated with a GdVO4 shell. FS1c_Size distribution histogram of the DyVO4 nanoparticles coated with a first YVO4 shell and with a second shell consisting of GdVO4 doped with Nd3+. FS2 FS2b_Size distribution histogram for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2c_ DLS curve in water suspension for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2d_XRD pattern for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2d_DyVO4_PDF FS2e_FTIR spectrum for the DyVO4 nanoparticles functionalized with PAA used as cores. FS2f_TGA curve for the DyVO4 nanoparticles functionalized with PAA used as cores., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset - Sodium lanthanide tungstate-based nanoparticles as bimodal contrast agents for in vivo high-field MRI and CT imaging

  • Gómez-González, Elisabet
  • Caro, Carlos
  • Núñez, Nuria O.
  • González-Mancebo, Daniel
  • Urbano-Gámez, Jesús D.
  • García-Martín, María L.
  • Ocaña, Manuel
Research on High-Field Magnetic Resonance Imaging (HF-MRI) has increased in recent years, aiming to improve diagnosis accuracy by increasing the signal-to-noise ratio and hence image quality. Conventional contrast agents (CAs) have important limitations for HF-MRI, with the consequent need for the development of new CAs. Among the most promising alternatives are those based on Dy3+ or Ho3+ compounds. Notably, the high atomic number of lanthanide cations would bestow a high capability for X-ray attenuation to such Dy or Ho-based compounds, which would allow them to be also employed as CAs for X-ray computed tomography (CT). In this work, we have prepared uniform NaDy(WO4)2 and NaHo(WO4)2 nanoparticles NPs, which were dispersible under conditions that mimic the physiological media and were nontoxic for cells, meeting the main requirements for their use in vivo. Both NPs exhibited satisfactory magnetic relaxivities at 9.4T, thus making them a promising alternative to clinical CAs for HF-MRI. Furthermore, after their intravenous administration in tumor-bearing mice, both NPs exhibited significant accumulation inside the tumor at 24 h, attributable to passive targeting by the Enhanced Permeability and Retention (EPR) effect. Therefore, our NPs are suitable for detection of tumors through HF-MRI. Finally, NaDy(WO4)2 NPs showed a superior X-ray attenuation capability than iohexol (commercial CT CA), which, along with their high r2 value, makes them suitable as dual-probe for dual HF-MRI and CT imaging, as demonstrated by in vivo experiments conducted using healthy mice., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged., Elisabet Gómez-González, Carlos Caro, Nuria O. Núñez, Daniel González-Mancebo, Jesús D. Urbano-Gámez, María L. García-Martín and Manuel Ocaña. Sodium lanthanide tungstate-based nanoparticles as bimodal contrast agents for in vivo high-field MRI and CT imaging. Journal of Materials Chemistry B [In press], Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Lanthanide vanadate-based nanoparticles as multimodal T1 -T2 MRI contrast agent and NIR luminescent imaging probe

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L.
  • Becerro, Ana Isabel
  • Ocaña, Manuel
We report the development of a multimodal lanthanide vanadate system suitable as dual T1-T2 MRI contrast agent as well as a luminescent imaging probe in the near-infrared region, using Dy3+ and Gd3+ as T2 and T1 components, respectively, and Nd3+ as the luminescent center. The vanadate matrix was chosen to avoid the undesired solubility associated to previously reported fluoride-based contrast agents. With such aim, we first optimized the design of the MRI system by comparatively evaluating the magnetic relaxivities of two different architectures consisting of i) uniform NPs incorporating both paramagnetic cations in solid solution (single-phase NPs), and ii) core-shell NPs consisting of a DyVO4 core coated with a homogeneous GdVO4 shell (DyVO4@GdVO4). We found that, although both samples presented magnetic relaxivity properties that make them adequate for their use as dual T1-T2 contrast agents for magnetic resonance imaging, the core-shell architecture would be more suitable because of their higher magnetic relaxivity values. Secondly, to prepare the multimodal system, the GdVO4 layer of such optimal dual T1-T2 MRI probe was doped with Nd3+ cations. An inert YVO4 intermediate shell was also introduced between the cores and the outer layer aiming to avoid energy transfer from Nd3+ to Dy3+, which would cause luminescence quenching. These core-shell-shell nanoparticles showed magnetic relaxivity values similar to those of the core-shell system and an intense luminescence in the near-infrared region. Moreover, they were dispersible and chemically stable under conditions that mimic the physiological media, and they were nontoxic for cells. Therefore, such multimodal nanoparticles meet the main requirements for their use as a dual T1-T2 contrast agent for magnetic resonance imaging and as a probe for luminescent imaging in the near-infrared region., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your Future” is also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sodium lanthanide tungstate-based nanoparticles as bimodal contrast agents for in vivo high-field MRI and CT imaging

  • Gómez-González, Elisabet
  • Caro, Carlos
  • Núñez, Nuria O.
  • González-Mancebo, Daniel
  • Urbano-Gámez, Jesús D.
  • García-Martín, María L.
  • Ocaña, Manuel
Research on High-Field Magnetic Resonance Imaging (HF-MRI) has increased in recent years, aiming to improve diagnosis accuracy by increasing the signal-to-noise ratio and hence image quality. Conventional contrast agents (CAs) have important limitations for HF-MRI, with the consequent need for the development of new CAs. Among the most promising alternatives are those based on Dy3+ or Ho3+ compounds. Notably, the high atomic number of lanthanide cations would bestow a high capability for X-ray attenuation to such Dy or Ho-based compounds, which would allow them to be also employed as CAs for X-ray computed tomography (CT). In this work, we have prepared uniform NaDy(WO4)2 and NaHo(WO4)2 nanoparticles NPs, which were dispersible under conditions that mimic the physiological media and were nontoxic for cells, meeting the main requirements for their use in vivo. Both NPs exhibited satisfactory magnetic relaxivities at 9.4T, thus making them a promising alternative to clinical CAs for HF-MRI. Furthermore, after their intravenous administration in tumor-bearing mice, both NPs exhibited significant accumulation inside the tumor at 24 h, attributable to passive targeting by the Enhanced Permeability and Retention (EPR) effect. Therefore, our NPs are suitable for detection of tumors through HF-MRI. Finally, NaDy(WO4)2 NPs showed a superior X-ray attenuation capability than iohexol (commercial CT CA), which, along with their high r2 value, makes them suitable as dual-probe for dual HF-MRI and CT imaging, as demonstrated by in vivo experiments conducted using healthy mice., This publication is part of the I + D + I Grants PID2021-122328OB-I00 and PID2020-118448RB-C21, funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. This work was supported as well by Junta de Andalucía under grant no. P20_00182, co-financed by EU FEDER funds. Grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” is also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Realization of Extreme Nonstoichiometry in Gadolinium Aluminate Garnets by Glass Crystallization Synthesis

  • Fang, Xue
  • Castaing, Victor
  • Becerro, Ana Isabel
  • Cao, Weiwei
  • Veron, Emmanuel
  • Zanghi, Didier
  • Dyer, Matthew S.
  • Genevois, Cécile
  • Allix, Mathieu
  • Pitcher, Michael J.
The garnet aluminates RE3Al5O12 (RE = Gd - Lu, Y) are an important class of optical materials with a range of applications. Typically, they do not tolerate large deviations from ideal stoichiometry, and their luminescence properties are controlled by dopant selection rather than modification of the host structure. Here, we use glass crystallization as a nonequilibrium synthesis route to a new family of highly nonstoichiometric gadolinium aluminate garnets, of formula Gd3+xAl5-xO12 with x ≤ 0.60. Remarkably, this range is much broader than the previously reported Y3+xAl5-xO12 series (x ≤ 0.4), despite the vast size contrast between Al3+ and Gd3+, which are forced to share a crystallographic site in the nonstoichiometric materials: the endmember Gd3.6Al4.4O12 lies halfway between ideal garnet and perovskite stoichiometries, with 30% of its octahedral Al3+ sites substituted by Gd3+. In principle, this crystal chemistry should allow the synthesis of phosphor systems with rare-earth activators distributed over two different cation sublattices. To probe the response of luminescence properties to extreme nonstoichiometry in Gd3+xAl5-xO12, we synthesized three model phosphor systems by doping with Ce3+, Tb3+, or Tm3+/Yb3+ and found that upconversion (Tm3+/Yb3+) phosphors have the most potential to be tuned by this approach. These results demonstrate that highly nonstoichiometric garnet aluminates are not limited to small rare-earth hosts such as YAG, opening new opportunities for development of different garnet-based optical and magnetic materials., Funding was provided by the French National Research Agency (ANR) under projects 20-CE08-0007 CAPRE and ANR-23-CE08-0013-01 HighFive, and by the I + D + I Grant PID2021-122328OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Electron microscopy facilities were provided by the Platform MACLE - CVL, cofunded by the European Union and the Centre-Val de Loire Region (FEDER). Xue Fang acknowledges the China Scholarship Council (CSC) for a PhD scholarship (project 202008450026). Victor Castaing thanks Junta de Andalucía for financial support (POSTDOC_21_00694). Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. This work used the Cirrus UK National Tier-2 HPC Service at EPCC (http://www.cirrus.ac.uk) funded by the University of Edinburgh and EPSRC (EP/P020267/1). Access to the SAMBA beamline (SOLEIL synchrotron, Gif-sur-Yvette, France) was granted under proposal 20211197. We thank Dr. Emiliano Fonda for assistance with EXAFS data collection, Sandra Ory (CEMHTI, Orléans) for DSC measurements and TEM sample preparation, and Pierre-Loup Savary (CEMHTI, Orléans) for preparation of additional glass precursors., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset - Cr3+-doped gamma-and beta-Gallium Oxide Nanoprobes for Bioimaging: Synthesis, Persistent luminescence and Biocompatibility

  • Arroyo, Encarnación
  • Monje-Moreno, José Manuel
  • Torres-Herrero, Beatriz
  • Muñoz-Ruiz, Manuel Jesús
  • Fuente, Jesús M. de la
  • Becerro, Ana Isabel
  • Ocaña, Manuel
File List: Fig 1b: Size histogram of undoped gamma-Ga2O3 particles Fig 1c: DLS curve in aqueous suspension of undoped gamma-Ga2O3 particles Fig 1d : XRD pattern of undoped gamma-Ga2O3 particles Fig 1f: TG curve of undoped gamma-Ga2O3 particles Fig 2e: Particle size distributions and normal fitted curves of gamma-Ga2O3 particles doped with 0.1 %, 0.5 %, and 2.0 % Cr3+. Fig 2f: DLS curves of particles shown in (a) to (d) suspended in distilled water. Fig 3a: PLE spectrum of gamma-Ga2O3: 0.5 % Cr3+. Fig 3b: PL spectra of gamma-Ga2O3: x % Cr3+. Fig 3c: PersL decay curves of gamma-Ga2O3: x% Cr3+ after being illuminated with UV light (260 nm) for 5 min Fig 3d: PersL decay curves of gamma-Ga2O3: 2.0 % Cr3+ after being illuminated with UV light (260 nm) for 5 min recorded at two different emission wavelengths Fig 4b: FTIR spectra of the NPs@SiO2 and final NPs Fig 4c: Particle size distributions of the NPs@SiO2 and final NPs Fig 4d: DLS curves in aqueous suspension (pH 6) (d) of the NPs@SiO2 and final NPs Fig 4f: XRD pattern of the final NPs Fig 5a, 5b and 5c:Comparison of the photoluminescence properties of -Ga2O3 and gamma-Ga2O3 NPs. a) Absolute PL spectra, b) Normalized PL spectra, and c) PersL decay curves Fig 6a: PLE and PersL excitation spectra of beta-Ga2O3 NPs Fig 6b: PL and PersL emission spectra of beta-Ga2O3 NPs Fig 8a: DLS curves of beta-Ga2O3:2 % Cr3+ NPs dispersed in MES. Fig 8b: Zavg and PdI values as a function of time, obtained from DLS measurements on beta-Ga2O3:2 % Cr3+ NPs dispersed in MES. Fig 10: Cell viability assay of MIA PaCa-2 cell line exposed to different concentrations of beta-Ga2O3:2 % Cr3+ NPs for 24 h. Fig 11d: EDX spectrum of the region marked with a quadrangle in Fig 11b. Fig 12: Viability (a) and brood size (b) of N2 worms incubated at 20°C with different concentrations (mg·mL-1) of beta-Ga2O3:2 % Cr3+ NPs for 24h., Persistent luminescent nanophosphors that emit in the near infrared region are promising nanoprobes for in-vivo bioimaging. Although Cr3+-doped zinc gallate nanoparticles have been widely studied as in-vivo bioimaging nanoprobes due to their NIR persistent luminescence emission at 695 nm, the simpler Cr3+-doped gallium oxide system has been less explored despite its deeper NIR emission (760 nm), which favours tissue penetration. This is likely due the lack of synthesis methods that render Ga2O3-based nanoparticles suitable for in-vivo applications. In this paper, we report a novel method for the synthesis of uniform and hydrophilic -Ga2O3:Cr3+ nanoparticles, whose photoluminescence and persistent luminescence were optimized by adjusting their Cr3+ content. Such properties were further greatly improved through an annealing process at high temperature, which resulted in the transformation of its crystal structure into the -phase. The obtained -Ga2O3:Cr3+ nanoparticles were colloidally stable in a physiological pH simulator medium and were nontoxic for cells. Finally, we also studied, for the first time in literature, the in-vivo biocompatibility of such nanoparticles using a C. elegans animal model, finding that their morbidity and reproductive toxicity were negligible. In summary, the reported nanoparticles are excellent candidates for their use as a NIR persistent luminescence probes for in-vivo bioimaging., This publication is part of the I + D + I grant PID2021-122328OB-I00 funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. E.A. acknowledges Grant FPU19/00527 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. B.T.H. acknowledges Grant FPU19/01311 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”. Authors would like to acknowledge the use of Servicios Científico-Técnicos del CIBA (IACS-Universidad de Zaragoza), specifically to the Preclinical Imaging and phenotyping Unit., File List: Fig 1b: Size histogram of undoped gamma-Ga2O3 particles Fig 1c: DLS curve in aqueous suspension of undoped gamma-Ga2O3 particles Fig 1d : XRD pattern of undoped gamma-Ga2O3 particles Fig 1f: TG curve of undoped gamma-Ga2O3 particles Fig 2e: Particle size distributions and normal fitted curves of gamma-Ga2O3 particles doped with 0.1 %, 0.5 %, and 2.0 % Cr3+. Fig 2f: DLS curves of particles shown in (a) to (d) suspended in distilled water. Fig 3a: PLE spectrum of gamma-Ga2O3: 0.5 % Cr3+. Fig 3b: PL spectra of gamma-Ga2O3: x % Cr3+. Fig 3c: PersL decay curves of gamma-Ga2O3: x% Cr3+ after being illuminated with UV light (260 nm) for 5 min Fig 3d: PersL decay curves of gamma-Ga2O3: 2.0 % Cr3+ after being illuminated with UV light (260 nm) for 5 min recorded at two different emission wavelengths Fig 4b: FTIR spectra of the NPs@SiO2 and final NPs Fig 4c: Particle size distributions of the NPs@SiO2 and final NPs Fig 4d: DLS curves in aqueous suspension (pH 6) (d) of the NPs@SiO2 and final NPs Fig 4f: XRD pattern of the final NPs Fig 5a, 5b and 5c:Comparison of the photoluminescence properties of -Ga2O3 and gamma-Ga2O3 NPs. a) Absolute PL spectra, b) Normalized PL spectra, and c) PersL decay curves Fig 6a: PLE and PersL excitation spectra of beta-Ga2O3 NPs Fig 6b: PL and PersL emission spectra of beta-Ga2O3 NPs Fig 8a: DLS curves of beta-Ga2O3:2 % Cr3+ NPs dispersed in MES. Fig 8b: Zavg and PdI values as a function of time, obtained from DLS measurements on beta-Ga2O3:2 % Cr3+ NPs dispersed in MES. Fig 10: Cell viability assay of MIA PaCa-2 cell line exposed to different concentrations of beta-Ga2O3:2 % Cr3+ NPs for 24 h. Fig 11d: EDX spectrum of the region marked with a quadrangle in Fig 11b. Fig 12: Viability (a) and brood size (b) of N2 worms incubated at 20°C with different concentrations (mg·mL-1) of beta-Ga2O3:2 % Cr3+ NPs for 24h., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cr3+-doped γ- and β-gallium oxide nanoprobes for bioimaging: Synthesis, persistent luminescence, and biocompatibility

  • Arroyo, Encarnación
  • Monje-Moreno, José Manuel
  • Torres-Herrero, Beatriz
  • Muñoz-Ruiz, Manuel Jesús
  • Fuente, Jesús M. de la
  • Becerro, Ana Isabel
  • Ocaña, Manuel
Persistent luminescent (PersL) nanophosphors that emit in the near infrared (NIR) region are promising nanoprobes for in vivo bioimaging. Although Cr3+-doped zinc gallate nanoparticles (NPs) have been widely studied as in vivo bioimaging nanoprobes due to their NIR PersL emission at 695 nm, the simpler Cr3+-doped gallium oxide system has been less explored despite its deeper NIR emission (760 nm), which favors tissue penetration. This is likely due the lack of synthesis methods that render Ga2O3-based NPs suitable for in vivo applications. In this paper, a novel method for the synthesis of uniform and hydrophilic γ-Ga2O3:Cr3+ NPs is reported, whose photoluminescence (PL) and PersL are optimized by adjusting their Cr3+ content. Such properties are further greatly improved through an annealing process at high temperature, which result in the transformation of its crystal structure into the β-phase. The obtained β-Ga2O3:Cr3+ NPs are colloidally stable in a physiological pH simulator medium and are nontoxic for cells. Finally, this work studies, for the first time in literature, the in vivo biocompatibility of such NPs using a Caenorhabditis elegans (C. elegans) animal model, finding that their morbidity and reproductive toxicity are negligible. In summary, the reported NPs are excellent candidates for their use as a NIR PersL probes for in vivo bioimaging., This publication is part of the I + D + I grant PID2021-122328OB-I00 funded by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. E.A. acknowledges Grant FPU19/00527 funded by MICIU/AEI/10.13039/501100011033 and by “ESF Investing in your future”. B.T.H. acknowledges Grant FPU19/01311 funded by MICIU/AEI/10.13039/501100011033 and by “ESF Investing in your future”. Authors would like to acknowledge the use of Servicios Científico-Técnicos del CIBA (IACS-Universidad de Zaragoza), specifically to the Preclinical Imaging and phenotyping Unit., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

Dataset -Sodium lanthanide tungstate-based nanoparticles as bimodal probes for T1-T2 magnetic resonance imaging and X-ray computed tomography

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L
  • Monje-Moreno, José Manuel
  • Hamdi, Amel
  • López-Larrubia, Pilar
  • Becerro, Ana Isabel
  • Ocaña, Manuel
Files List: Figure 1 F1b_Particle size histogram (b) of the synthesized nanoparticles Figure 2 F2a_blue XRD pattern of the synthesized nanoparticles F2a_red ticks corresponding to the tetragonal NaDy(WO4)2 (25-829 PDF file). F2b_FTIR spectrum of the tetragonal NaDy(WO4)2 nanoparticles F2c_TGA curve of the tetragonal NaDy(WO4)2 nanoparticles. Figure 3 F3_MES_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 0 h. F3_MES_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 24 h. F3_MES_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 48 h. F3_MES_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in MES, and aged undisturbed at 37ºC for 72 h. F3_Saline_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 0 h. F3_Saline_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 24 h. F3_Saline_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 48 h. F3_Saline_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in saline, and aged undisturbed at 37ºC for 72 h. F3_Water_black_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 0 h. F3_Water_blue_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 24 h. F3_Water_green_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 48 h. F3_Water_red_DLS curve obtained for the NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water, and aged undisturbed at 37ºC for 72 h. Figure 5 F5c_Percentage of dead cells obtained from live-dead analysis F5d_black_Negative and positive control for live-dead analysis F5d_cyan_total number of cells per well obtained from live-dead analysis Figure 6 F6_black_negative and positive control for MTT assay F6_cyan_Mitochondrial activity of cells exposed to increasing concentration of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles evaluated by MTT assay Figure 7 F7c_EDX spectrum taken from the region marked with a white square in Figure 7 (a). Figure 8 F8_left_Viability of N2 worms incubated at 20°C with different NaDy0.44Gd0.56(WO4)2@PAA nanoparticles concentrations for 24h F8_right_Brood size (right) of N2 worms incubated at 20°C with different NaDy0.44Gd0.56(WO4)2@PAA nanoparticles concentrations for 24h Figure 9 F9a_blue_Relaxation rates 1/T1 measured at 3 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9a_red_Relaxation rates 1/T1 measured at 1.44 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9b_blue_Relaxation rates 1/T2 measured at 3 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles F9b_red__Relaxation rates 1/T2 measured at 1.44 T for aqueous dispersions of the NaDy0.44Gd0.56(WO4)2@PAA nanoparticles Figure 11 F11_green_X-ray attenuation values (in Hounsfield units, HU) of NaDy0.44Gd0.56(WO4)2@PAA NPs dispersed in water F11_ red_X-ray attenuation values (in Hounsfield units, HU) of iohexol dispersed in water, Magnetic resonance imaging (MRI) is one of the most used imaging techniques for diagnosis in clinics. Often, magnetically-active substances, called contrast agents (CAs), have to be used, which increase contrast by shortening the longitudinal (T1) (resulting in signal enhancement in T1-weigthed images) and/or transverse (T2) (resulting in signal decay in T2-weighted images) relaxation times of the water protons present in biological tissues. A further strategy to improve diagnostic accuracy is recording both kinds of images (T1-weighted and T2-weighted) using dual T1-T2 CAs, which facilitates the exclusion of false positives. The traditional T1 or T2 contrast agents are not suitable for such a purpose. This paper deals with the development of double sodium lanthanide tungstate-based nanoparticles containing Gd3+ and Dy3+ cations, which are dispersible in physiological media, do not show appreciable in vitro (for human fibroblast cells) and in vivo (for C-elegans) toxicity and present appropriate relaxivity values for their use as a dual T1-T2 contrast agent for magnetic resonance imaging. In addition, they show an excellent X-ray attenuation capacity, thanks, mainly, to their tungsten content, which makes them also useful for X-ray computed tomography. Hence, the developed nanoparticles are ideal multimodal probes to be used as a dual T1-T2 contrast agent for magnetic resonance imaging and as a contrast agent for X-ray computed tomography., This publication is part of the I + D + I Grants PID2021-122328OB-I00, PID2020-118448RB-C21 and PID2021-122528OB-I00, funded by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Financial support was also provided by Junta de Andalucía (P20_00182). DIAMOND network RED2022-134299-T funded by MICIN and grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” are also acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Sodium lanthanide tungstate-based nanoparticles as bimodal probes for T1-T2 magnetic resonance imaging and X-ray computed tomography

  • Gómez-González, Elisabet
  • Núñez, Nuria O.
  • Caro, Carlos
  • García-Martín, María L
  • Monje-Moreno, José Manuel
  • Hamdi, Amel
  • López-Larrubia, Pilar
  • Becerro, Ana Isabel
  • Ocaña, Manuel
Magnetic resonance imaging (MRI) is one of the most used imaging techniques for diagnosis in clinics. Often, magnetically-active substances, called contrast agents (CAs), have to be used, Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Open Access Article. Published on 10 October 2025. Downloaded on 10/10/2025 10:25:41 AM. This article is licensed under a which increase contrast by shortening the longitudinal (T1) (resulting in signal enhancement in T1-weigthed images) and/or transverse (T2) (resulting in signal decay in T2-weighted images) relaxation times of the water protons present in biological tissues. A further strategy to improve diagnostic accuracy is recording both kinds of images (T1-weighted and T2-weighted) using dual T1-T2 CAs, which facilitates the exclusion of false positives. The traditional T1 or T2 contrast agents are not suitable for such a purpose. This paper deals with the development of double sodium lanthanide tungstate-based nanoparticles containing Gd3+ and Dy3+ cations, which are dispersible in physiological media, do not show appreciable in vitro (for human fibroblast cells) and in vivo (for C-elegans) toxicity and present appropriate relaxivity values for their use as a dual T1-T2 contrast agent for magnetic resonance imaging. In addition, they show an excellent X-ray attenuation capacity, thanks, mainly, to their tungsten content, which makes them also useful for X-ray computed tomography. Hence, the developed nanoparticles are ideal multimodal probes to be used as a dual T1-T2 contrast agent for magnetic resonance imaging and as a contrast agent for X-ray computed tomography., This publication is part of the I + D + I Grants PID2021-122328OB-I00, PID2020118448RB-C21 and PID2021-122528OB-I00, funded by MICIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. Financial support was also provided by Junta de Andalucía (P20_00182). DIAMOND network RED2022-134299-T funded by MICIN and grant PRE2019-090170 funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future” are also acknowledged. Relaxivity measurements were performed at the ICTS “NANBIOSIS”, specifically in Unit 28 at the “Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina (IBIMA Plataforma BIONAND)”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Persistent Luminescence in Highly Nonstoichiometric GAGG Garnets Gd3+x[Al2Ga3]1-x/5O12 (0 ≤ x ≤ 0.6) Doped with Ce3+/Cr3+

  • Fang, Xue
  • Vigier, Maxence
  • Castaing, Victor
  • Becerro, Ana Isabel
  • Lozano, Gabriel
  • Veron, Emmanuel
  • Pitcher, Michael J.
  • Allix, Mathieu
The gadolinium garnet Gd3Al2Ga3O12 co-doped with Ce3+ and Cr3+ (GAGG-Ce,Cr) has been widely studied due to its unusual bright yellow long-lasting persistent luminescence properties. Here, rapid containerless melt-quenching is used as part of a two-step glass-crystallisation synthesis process to obtain a new highly nonstoichiometric form of this garnet, of composition Gd3+x[Al2Ga3]1-x/5O12 with 0 ≤ x ≤ 0.6 (ns-GAGG). For compositions x > 0, powder X-ray diffraction analysis confirms that excess Gd3+ is accommodated at the Al3+/Ga3+ sublattice in octahedral coordination, by substituting up to 30% of these sites. This mode of substitution complexifies the local structure of the garnet host, which is shown to influence certain luminescence properties in the analogous highly nonstoichiometric Y3+xAl5-xO12 (0 < x < 0.4) and Gd3+xAl5-xO12 (0 < x < 0.6) systems. Co-doping ns-GAGG with Ce3+ and Cr3+ produces green-yellow persistent luminescence when x = 0, which undergoes a redshift to yellow-orange as the Gd3+ content increases to x = 0.4. However, this radical modification of the host composition does not strongly affect the afterglow kinetics. These results demonstrate an effective and high-precision way of decoupling color and kinetics in persistent luminescent garnets, which is usually hard to achieve using the standard stoichiometric material engineering approach., X.F. thanks the China Scholarship Council for a PhD bursary (project 202008450026). Funding was provided by the French National Research Agency (ANR) under ANR-23-CE08-0013-01 HighFive and Grant PID2021-122328OB-I00 by MICIU/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe”. Electron microscopy facilities were provided by the Platform MACLE-CVL, co-funded by the European Union and the Centre-Val de Loire Region (FEDER). The authors thank Sandra Ory (CEMHTI) for DSC measurements., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Cr3+-Doped γ- and β-Gallium Oxide Nanoprobes for Bioimaging: Synthesis, Persistent Luminescence, and Biocompatibility

  • Arroyo, Encarnación
  • Monje-Moreno, José M.
  • Torres-Herrero, Beatriz
  • Munoz, Manuel J.
  • Martínez de la Fuente, Jesús
  • Becerro, Ana I.
  • Ocaña, Manuel
Persistent luminescent (PersL) nanophosphors that emit in the near infrared (NIR) region are promising nanoprobes for in vivo bioimaging. Although Cr3+‐doped zinc gallate nanoparticles (NPs) have been widely studied as in vivo bioimaging nanoprobes due to their NIR PersL emission at 695 nm, the simpler Cr3+‐doped gallium oxide system has been less explored despite its deeper NIR emission (760 nm), which favors tissue penetration. This is likely due the lack of synthesis methods that render Ga2O3‐based NPs suitable for in vivo applications. In this paper, a novel method for the synthesis of uniform and hydrophilic γ‐Ga2O3:Cr3+ NPs is reported, whose photoluminescence (PL) and PersL are optimized by adjusting their Cr3+ content. Such properties are further greatly improved through an annealing process at high temperature, which result in the transformation of its crystal structure into the β‐phase. The obtained β‐Ga2O3:Cr3+ NPs are colloidally stable in a physiological pH simulator medium and are nontoxic for cells. Finally, this work studies, for the first time in literature, the in vivo biocompatibility of such NPs using a Caenorhabditis elegans (C. elegans) animal model, finding that their morbidity and reproductive toxicity are negligible. In summary, the reported NPs are excellent candidates for their use as a NIR PersL probes for in vivo bioimaging.